The 2 analysts offering 12-month price forecasts for Elevation Oncology Inc have a median target of 9.50, with a high estimate of 11.00 and a low estimate of 8.00. The median estimate represents a +648.03% increase from the last price of 1.27.
The current consensus among 4 polled investment analysts is to Buy stock in Elevation Oncology Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$1.47
Reporting Date Nov 11
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.